Clinical Trials Logo
  1. Home
  2. Liver Dysfunction
  3. NCT06126419

Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

Liver Metastasis Colon Cancer Clinical Trial

Official title:
Application of High-Dose Insulin Therapy Using a Hyperinsulinemic Normoglycemic Clamp to Improve Liver Function and Regeneration

Clinical Trial Summary

The primary objective of this interventional study is determine if the future liver remnant can be optimized by improving liver function pre-operatively in patients who are scheduled for major hepatectomy. The main questions it aims to answer are: 1. Does high-dose insulin therapy improve liver function in the pre-operative setting? 2. What is the effect of high-dose insulin therapy on liver function and liver regeneration after a liver venous deprivation (LVD) procedure? 3. What is the relationship between volume hypertrophy and function in the regenerating liver? Participants will receive a 6-hour infusion of insulin and dextrose to maintain a hyperinsulinemic-normoglycemic state in the weeks prior to planned liver surgery to assess its effect on liver function measured by 99m-Tc-Mebrofenin hepatobiliary scintigraphy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06126419
Study type Interventional
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact
Status Recruiting
Phase N/A
Start date November 8, 2023
Completion date July 2025
View Details
See also
  Status Clinical Trial Phase
Suspended NCT04108481 - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer Phase 1/Phase 2
Recruiting NCT03562234 - The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases
Recruiting NCT03732235 - TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Active, not recruiting NCT05616039 - I-FIGS Feasibility Study N/A
Withdrawn NCT05175092 - Living Donor Liver Transplantation for CRC Liver Metastases N/A
Recruiting NCT04798898 - Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation N/A
Not yet recruiting NCT06071052 - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens N/A
Not yet recruiting NCT06053996 - Hepatopulmonary Radio-sterilization With Immunotherapy N/A
Recruiting NCT04491929 - Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Not yet recruiting NCT06050200 - TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery N/A
Enrolling by invitation NCT03444194 - Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study N/A
Not yet recruiting NCT05884723 - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis N/A
Not yet recruiting NCT06185556 - COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases Phase 2/Phase 3
Recruiting NCT05755672 - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Recruiting NCT04595266 - Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease Phase 2
Recruiting NCT04701281 - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer Phase 1/Phase 2
Recruiting NCT05775146 - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases Phase 2
Recruiting NCT06200831 - Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases N/A
Active, not recruiting NCT04046445 - Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer Phase 1
Recruiting NCT03088150 - COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation N/A